Home › Myelodysplastic Syndromes
Pag-aaral pangklinika para sa Myelodysplastic Syndromes na nagre-recruit sa U.S.
158 pag-aaral para sa Myelodysplastic Syndromes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX44 pag-aaral
- Baldwin Park, CA26 pag-aaral
- Seattle, WA21 pag-aaral
- New York City, NY21 pag-aaral
- Boston, MA20 pag-aaral
- Washington, DC20 pag-aaral
- Tampa, FL19 pag-aaral
- Miami, FL17 pag-aaral
- Chicago, IL14 pag-aaral
- Columbus, OH14 pag-aaral
- St. Louis, MO14 pag-aaral
- Durham, NC14 pag-aaral
- Atlanta, GA13 pag-aaral
- Nashville, TN11 pag-aaral
- Cleveland, OH11 pag-aaral
- Birmingham, AL10 pag-aaral
- Philadelphia, PA10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Mountain View, CA9 pag-aaral
- The Bronx, NY9 pag-aaral
- Jacksonville, FL9 pag-aaral
- Baltimore, MD9 pag-aaral
- Winston-Salem, NC9 pag-aaral
- Pittsburgh, PA9 pag-aaral
- New Haven, CT9 pag-aaral
- Portland, OR8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Clifton, NJ8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Buffalo, NY8 pag-aaral
- Salt Lake City, UT8 pag-aaral
- Edison, NJ7 pag-aaral
- Orange, CA7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Kansas City, MO7 pag-aaral
- Memphis, TN7 pag-aaral
- San Francisco, CA6 pag-aaral
- Aurora, CO6 pag-aaral
- Rochester, MN6 pag-aaral
- Charlottesville, VA6 pag-aaral
Ayos sa estado
- Alabama10 pag-aaral
- Arizona9 pag-aaral
- Arkansas4 pag-aaral
- California41 pag-aaral
- Colorado8 pag-aaral
- Connecticut11 pag-aaral
- District of Columbia4 pag-aaral
- Florida31 pag-aaral
- Georgia15 pag-aaral
- Hawaii3 pag-aaral
- Idaho4 pag-aaral
- Illinois17 pag-aaral
- Indiana4 pag-aaral
- Iowa7 pag-aaral
- Kansas5 pag-aaral
- Kentucky5 pag-aaral
- Louisiana5 pag-aaral
- Maine4 pag-aaral
- Maryland23 pag-aaral
- Massachusetts22 pag-aaral
- Michigan8 pag-aaral
- Minnesota13 pag-aaral
- Mississippi3 pag-aaral
- Missouri16 pag-aaral
- Montana3 pag-aaral
- Nebraska4 pag-aaral
- Nevada3 pag-aaral
- New Hampshire5 pag-aaral
- New Jersey14 pag-aaral
- New Mexico4 pag-aaral
- New York38 pag-aaral
- North Carolina19 pag-aaral
- North Dakota4 pag-aaral
- Ohio22 pag-aaral
- Oklahoma4 pag-aaral
- Oregon10 pag-aaral
- Pennsylvania17 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina7 pag-aaral
- Tennessee15 pag-aaral
- Texas45 pag-aaral
- Utah8 pag-aaral
- Vermont3 pag-aaral
- Virginia8 pag-aaral
- Washington21 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin11 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Nagre-recruitObservasyonal na pag-aaral
1 Day – 99 Years · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07683104The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Nagre-recruitPhase 1/2
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06303193Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06904066A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
Edad 12 hanggang 78 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03802695Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06484062CHIP/CCUS Natural History Protocol
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548230Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03661307Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06577441Natural History Study of GATA2 Deficiency and Related Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01905826Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Nagre-recruitPhase 2
Edad 4 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01174108A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Nagre-recruitPhase 1
Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03630991Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04282187CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04375631Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
2 Months · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06904482Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04771130Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06846606Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03471260Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.